Royal Enfield Records 35% Decline in June Sales
Niche bike maker Royal Enfield has reported a 35 per cent decline in total sales at 38,065 units in June. The company had registered total sales of...
Author : Amrita Chakravorty
Google and Apple Start Blocking Banned Chinese Apps
Google has started temporarily blocking access to the banned Chinese apps that remained on the Play Store, the company said in a statement. While Apple hasn’t officially...
SEBI Imposes Penalty on Divi’s Labs Insiders
The Securities and Exchange Board of India (SEBI) has imposed over Rs96 lakh penalty on Divi’s Laboratories’ Chief Financial officer (CFO) L Kishore Babu and his close...
Gold Prices Today Fall For 2nd Day, Down Rs 800 per 10 Gram
Gold prices in India edged lower today for the second day after hitting a record high in the previous session. On MCX, gold futures were were...
J&J Ramps Up Production of Affordable Covid-19 Vaccine
Johnson & Johnson is preparing the ground for the entry of a vaccine against COVID-19 and is expanding its manufacturing capacity to supply more than one...
Swiggy Introduces Digital Wallet in Partnership With ICICI Bank
Food aggregator unicorn Swiggy has launched its own digital wallet Swiggy Money in partnership with ICICI Bank to enable a ‘single-click checkout experience’ on its platform. The full-fledged...
Vistara Announces 5-20% Pay Cut for 40% Employees Till Dec
Vistara has announced a pay cut between five to 20 per cent till December this year for around 40% of its employees as cash flow continues...
800 Million Poor to Get Free Grain Till Nov, Says PM Modi
Prime Minister Narendra Modi on Tuesday said 80 crore poor will get 5 kg of wheat or rice and 1 kg of gram every month till...
HC Declines Plea Seeking Free Private COVID-19 Test
The Delhi High Court on Tuesday declined to entertain a plea seeking free of cost COVID-19 testing and treatment at all private labs and hospitals in the national capital...
Shilpa Medicare Gains 5% on Launch of Generic Drug
Shares of Shilpa Medicare gained as much as 5.23 per cent after the company launched generic drug to treat advanced kidney cancer. Shilpa Medicare was...